Fibrosarcoma in Dogs: Identifying and Treating Aggressive Skin Tumors

By Emiel Maddens · Reviewed in consultation with licensed veterinary professionals · Updated August 2026 · 9 min read

What Is Fibrosarcoma in Dogs?

Fibrosarcoma is a malignant tumor that develops from fibroblasts, the connective tissue cells that produce collagen in a dog's skin and subcutaneous tissue. It belongs to a broader group called soft tissue sarcomas (STS), cancers that arise from the fibrous, fatty, muscular, and vascular tissues beneath the skin.

Fibrosarcomas are considered locally aggressive but slow to spread. They infiltrate surrounding tissue with microscopic tendrils that extend well beyond the visible mass, which makes complete removal challenging. Studies estimate soft tissue sarcomas make up roughly 15% of all canine skin and subcutaneous tumors, with fibrosarcoma representing a meaningful share of that group (Dennis et al., 2011).

They most commonly appear on the limbs, trunk, and head. Larger breeds and middle-aged to older dogs, typically 7 to 10 years of age, are overrepresented. Golden Retrievers, Doberman Pinschers, and other large breeds show a higher incidence. While the mass itself may feel firm and fixed, its clinical danger comes from local invasion rather than early distant spread.

What Causes Fibrosarcoma in Dogs?

The exact cause of most canine fibrosarcomas is unknown, but several mechanisms and risk factors have been identified. At the cellular level, fibrosarcoma develops when fibroblasts accumulate genetic mutations that disrupt normal growth controls, allowing uncontrolled proliferation and local tissue invasion.

Known contributing factors include: chronic tissue trauma or scarring, prior radiation exposure, and in rare oral cases, a distinct biologically high-grade variant seen in large breed dogs. Unlike cats, dogs rarely develop injection-site or vaccine-associated sarcomas, though the phenomenon has been documented occasionally.

Genetic predisposition plays a role, as certain large and giant breeds are diagnosed more frequently than the general population would predict. Age is also a significant factor, with most tumors appearing in dogs older than seven. Importantly, fibrosarcoma is not caused by anything an owner did or failed to do, and it is not contagious to other pets or people.

How Do Veterinarians Diagnose Fibrosarcoma?

Veterinarians diagnose fibrosarcoma through a combination of physical examination, cytology, and definitive biopsy with histopathology. Because many skin lumps look similar on the surface, laboratory analysis is essential to distinguish fibrosarcoma from benign masses and other sarcomas.

The workup usually begins with a fine needle aspirate (FNA), a quick sampling technique that draws cells through a small needle. Soft tissue sarcomas often yield few cells on aspiration, so a normal or inconclusive FNA does not rule cancer out. When suspicion remains, an incisional or excisional biopsy provides tissue for histopathologic grading.

Grading is critical: pathologists assign a grade of 1 (low), 2 (intermediate), or 3 (high) based on cell differentiation, mitotic count, and the amount of necrosis. Grade strongly predicts behavior, with high-grade tumors carrying a metastatic rate near 40% compared with under 15% for low-grade tumors. Staging tests such as chest radiographs and regional lymph node evaluation help rule out spread before surgery. If you are unsure whether a lump warrants investigation, our Dog Skin Condition Checker can help you decide when to book a veterinary visit.

Signs and Symptoms to Watch For

The most common sign of fibrosarcoma is a firm, poorly movable mass under the skin that grows over weeks to months. Because these tumors are anchored to deeper tissue, they often feel fixed rather than freely mobile. The overlying skin may remain intact early on, then ulcerate as the mass enlarges.

The table below compares features that help distinguish a concerning mass from a more typical benign lump, though only biopsy can confirm the difference:

Treatment Options for Fibrosarcoma

Surgery is the cornerstone of fibrosarcoma treatment, and the goal is wide excision with clean margins to prevent local regrowth. Surgeons typically aim for 2 to 3 cm of lateral margin and at least one uninvolved fascial plane beneath the tumor. When complete margins are achieved, long-term control rates are excellent, but incomplete removal is associated with local recurrence in 30 to 50% of cases.

When surgery cannot fully clear the tumor, adjuvant radiation therapy improves local control, and studies report median disease-free intervals exceeding 700 days with combined surgery and radiation. Chemotherapy such as doxorubicin is reserved mainly for high-grade tumors or documented metastasis, since fibrosarcomas are only variably chemoresponsive.

Supportive skin care matters when a tumor ulcerates or after surgery leaves a large wound bed prone to irritation. Gentle, non-stinging cleansing helps keep the peritumoral or incisional skin comfortable. Itchy Skin Relief Shampoo contains colloidal oatmeal and aloe, ingredients that soothe inflamed, sensitized skin and support the surrounding barrier without harsh detergents, which can be useful for maintaining hygiene around a healing surgical site under veterinary guidance. For broader context on canine skin cancers and diagnostics, see our related coverage of Cutaneous Hemangiosarcoma in Dogs and Alopecia Areata in Dogs. You can also use the Dog Skin Condition Checker to review symptoms before your appointment.

What Is the Prognosis and Long-Term Management?

Prognosis for fibrosarcoma depends heavily on tumor grade and the completeness of surgical removal. Dogs with low-grade tumors that are fully excised often achieve long-term survival measured in years, whereas high-grade tumors carry a guarded outlook because of a metastatic rate approaching 40%.

Long-term management centers on regular rechecks. Veterinarians typically recommend physical exams every three months for the first year, then every six months, along with periodic chest radiographs to screen for spread. Owners should monitor the surgical site and any other lumps at home, measuring and photographing them to track changes.

Maintaining overall skin health supports comfort during recovery and surveillance. Keeping the coat clean, managing secondary irritation promptly, and reporting new masses early all improve outcomes. Because recurrence is the most common problem, catching a returning nodule while it is small gives the best chance for a second successful surgery.

Frequently Asked Questions

Is fibrosarcoma in dogs curable?

Fibrosarcoma can often be cured when it is low grade and completely removed with wide surgical margins of 2 to 3 cm. Low-grade, fully excised tumors carry survival measured in years, while high-grade tumors have a guarded prognosis due to a metastatic rate near 40%.

How fast does fibrosarcoma grow in dogs?

Most canine fibrosarcomas grow gradually over weeks to months rather than days. High-grade tumors tend to enlarge more quickly than low-grade ones, but even slow-growing masses can be locally aggressive and should be evaluated promptly.

Does fibrosarcoma spread to other organs in dogs?

Distant metastasis is uncommon overall, occurring in fewer than 10 to 20% of cases. However, high-grade fibrosarcomas can spread to the lungs in up to 40% of dogs, which is why grading and chest radiographs are part of staging.

How much does fibrosarcoma treatment cost for a dog?

Costs vary widely by tumor size, location, and whether radiation or chemotherapy is added. Wide surgical excision is the primary treatment, and adding radiation for incomplete margins increases both cost and the disease-free interval, which can exceed 700 days in combined-treatment studies.

Can a fibrosarcoma come back after surgery?

Yes. Local recurrence occurs in 30 to 50% of cases when margins are incomplete, because these tumors send microscopic projections into surrounding tissue. Regular rechecks every three to six months help catch any returning nodule while it is small and treatable.

Sources

1. Dennis MM, McSporran KD, Bacon NJ, et al. Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs. Veterinary Pathology. 2011;48(1):73-84.
2. Liptak JM, Forrest LJ. Soft Tissue Sarcomas. In: Withrow and MacEwen's Small Animal Clinical Oncology. 5th ed. Elsevier; 2013:356-380.
3. Bray JP. Soft tissue sarcoma in the dog: a review. Journal of Small Animal Practice. 2016;57(11):574-585.
4. Ehrhart N. Soft-tissue sarcomas in dogs: a review. Journal of the American Animal Hospital Association. 2005;41(4):241-246.
5. McSporran KD. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas. Veterinary Pathology. 2009;46(5):928-933.

Related Reading

• Cutaneous Hemangiosarcoma in Dogs: Signs, Staging, and Treatment Options
• Alopecia Areata in Dogs: Immune-Mediated Patchy Hair Loss
• Toxic Epidermal Necrolysis in Dogs: A Life-Threatening Skin Emergency

Emiel Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.

Veterinary review: All Vetified content is developed in consultation with licensed veterinary professionals and references peer-reviewed research published in journals including Veterinary Dermatology, JAVMA, and Journal of Small Animal Practice.